Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock Gains 5.50% This Week: Is It a Good Pick?

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is down -32.20% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BIO stock a score of 31 out of a possible 100.

That rank is chiefly influenced by a short-term technical score of 21. BIO's rank also includes a long-term technical score of 36.

BIO has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on BIO!

See Full BIO Report

What's Happening with BIO Stock Today

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is lower by -1.54% while the S&P 500 is up 0.21% as of 3:29 PM on Thursday, Jan 12. BIO is down -$7.12 from the previous closing price of $461.17 on volume of 80,454 shares. Over the past year the S&P 500 is lower by -15.83% while BIO is down -32.20%. BIO lost -$201.80 per share in the over the last 12 months. Click Here to get the full Stock Report for Bio-Rad Laboratories, Inc. Class A Common Stock stock.